HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 2,525.00
-35.00 (-1.37%)
At close: Apr 17, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 114.81 billion as of April 17, 2026. Its market cap has increased by 21.47% in one year.
Market Cap
114.81B
Enterprise Value
96.64B
Revenue
15.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,525.00
Market Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 114.81B, an increase of 564.05%. That is a compound annual growth rate of 7.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 114.81B | 45.45% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 495.10B |
| 3billion | 387.49B |
| GENINUS | 197.94B |
| Cytogen | 95.28B |
| Green Cross Medical Science | 81.10B |
| Protia | 64.64B |
| Seoulin Bioscience | 56.93B |
| GeneMatrix | 41.40B |